Newsroom
Sorted by: Latest
-
Bitcoin Life Granted Full Life Insurance Licence; Launches Regulated Bitcoin Product for International Investors
ST PETER PORT, Guernsey--(BUSINESS WIRE)--Bitcoin Life Granted Full Life Insurance Licence; Launches Regulated Bitcoin Product to bring BTC into a trusted, institutional financial framework...
-
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX expands Faecal Dx™ antigen testing platform in the United Kingdom with taeniid tapeworm detection for broader intestinal parasite screening....
-
IDEXX étend sa plateforme de tests antigéniques Fecal Dx en France avec la détection des ténias Taeniidae
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ : IDEXX), leader mondial de l'innovation dans le domaine de la santé animale, a annoncé aujourd'hui l'extension de sa plateforme de tests antigéniques Fecal Dx™ en France avec les ténias Taeniidae, incluant les espèces Taenia et Echinococcus. Reconnu pour détecter plus précocement jusqu'à deux fois plus d'infections parasitaires intestinales qu'avec une coproscopie seule,1 le test antigénique Fecal Dx offre une détection parasi...
-
Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Summary Bayer today announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline and end-stage kidney disease in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D), following the agency’s Priority Review of the supplemental New Drug Application (...
-
Deutsche Bank AG UK Regulatory Announcement: Value per Security
LONDON--(BUSINESS WIRE)-- DB ETC PLC Dated: 16 September 2026 COMPANY ANNOUNCEMENT Immediate Release 16 September 2026 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 15 September 2026 Series ISIN Currency Value per Se...
-
Pershing Square Holdings, Ltd. UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 15 September 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today released its regular weekly Net Asset Value (“NAV”) and performance returns on its website, https://pershingsquareholdings.com/performance/net-asset-value-and-returns/. The NAV and returns were computed as of the close of business on Tuesday, 15 September 2026. PSH NAV per share as of close of bu...
-
Vantor Selects EnduroSat and CACI to Build High-Revisit Pulse Satellite Fleet
WESTMINSTER, Colo.--(BUSINESS WIRE)--Vantor, the leader in unified spatial intelligence, today announced it has selected EnduroSat and CACI to develop and build the initial Vantor Pulse™ satellites, a fleet of 40 cm-class satellites designed to image the same location on Earth as often as every 15 minutes. Pulse will provide frequent, broad-area monitoring and feed Tensorglobe™, Vantor’s spatial intelligence platform, where its data can be fused with AI, 3D data, and high-resolution imagery to...
-
Deutsche Bank AG UK Regulatory Announcement: Issuance of Securities
LONDON--(BUSINESS WIRE)-- DB ETC PLC Dated: 16 September 2026 COMPANY ANNOUNCEMENT Immediate Release 16 September 2026 DB ETC plc (the Issuer) Law 1991 (as amended) with registered number 103781) Re: Issuance of ETC Securities Announcement The Issuer has agreed to issue ETC Securities for the following Series as set out in the table below. Series Tranche Number of Securities to be issued Trade Date Settlement Date ISIN: Series 04 - Xtrackers Physical Silver EUR Hedged ETC 456 4,000 14 Septem...
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Consort Healthcare (Birmingham) Funding GBP398,680,000 1.972per cent Index Linked Guaranteed Secured Bonds due 2044 ISSUE NAME. Our Ref. B24317 ISIN Code. XS0257525112 INTEREST AMT PER DENOM. CURRENCY CODE. GBP DAY BASIS. Actual/Actual ISMA (A006) NUM OF DAYS. 183 INTEREST RATE. 0 PCT VALUE DATE. 30/09/2026 INTEREST PERIOD. 31/03/2026 TO 30/09/2026 GBP 1,000.00 IS GBP 12.88 POOL FACTOR. 0.6215490...
-
Mediterranean Network for Haemoglobinopathies Launches in Rome, Connecting Clinical Experts and Patient Leaders to Advance Equitable Care
ROME--(BUSINESS WIRE)--The Mediterranean Network for Haemoglobinopathies (MNfH) was recently launched at Palazzo Wedekind in Rome, bringing together leading clinicians and patient representatives from Cyprus, Greece, and Italy, with the Thalassaemia International Federation (TIF). Supported by Avanzanite Bioscience as Founding Sponsor, the independent regional platform will connect expertise across borders, strengthen the patient voice, and turn shared knowledge into practical initiatives that...